Ufp Technologies (UFPT) Net Income towards Common Stockholders (2010 - 2026)
Ufp Technologies (UFPT) reported Net Income towards Common Stockholders of $17.5 million for Q1 2026, up 1.81% on a YoY basis from $17.2 million in Q1 2025, and little changed quarter-over-quarter from $17.6 million in Q4 2025.
Ufp Technologies (UFPT) Net Income towards Common Stockholders (2010 - 2026) Analysis & Trends
Ufp Technologies has reported Net Income towards Common Stockholders for 17 years, with the latest figure at $17.5 million in Q1 2026.
- For the quarter ending Q1 2026, Net Income towards Common Stockholders rose 1.81% year-over-year to $17.5 million; the trailing twelve-month figure through Mar 2026 stood at $68.6 million (up 8.12% YoY), and the FY2025 full-year result was $68.3 million, up 15.82% from the prior year.
- Net Income towards Common Stockholders for Q1 2026 stood at $17.5 million, roughly flat from $17.6 million in the prior quarter.
- The five-year high for Net Income towards Common Stockholders was $19.5 million in Q3 2022, with the low at $4.9 million in Q1 2022.
- Historically, Net Income towards Common Stockholders has averaged $13.6 million across 5 years, with a median of $13.6 million in 2024.
- Annual changes were most pronounced in 2022 — Net Income towards Common Stockholders jumped 415.7% — and 2023, when it tumbled 40.15%.
- Ufp Technologies' Net Income towards Common Stockholders stood at $8.5 million in 2022, then soared by 37.17% to $11.6 million in 2023, then jumped by 41.08% to $16.4 million in 2024, then increased by 7.27% to $17.6 million in 2025, then dropped by 0.4% to $17.5 million in 2026.
- The last three Net Income towards Common Stockholders figures came in at $17.5 million (Q1 2026), $17.6 million (Q4 2025), and $16.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | - |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 411.00 Mn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 187,319.30 |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 199.50 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | - |
| 10 | Ufp Technologies | 1.82 Bn | 1.80 Bn | 44.36 Mn | 17.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17.50 Mn |
| Dec 31, 2025 | 17.57 Mn |
| Sep 30, 2025 | 16.38 Mn |
| Jun 30, 2025 | 17.18 Mn |
| Mar 31, 2025 | 17.18 Mn |
| Dec 31, 2024 | 16.38 Mn |
| Sep 30, 2024 | 16.36 Mn |
| Jun 30, 2024 | 13.55 Mn |
| Mar 31, 2024 | 12.69 Mn |
| Dec 31, 2023 | 11.61 Mn |
| Sep 30, 2023 | 11.69 Mn |
| Jun 30, 2023 | 11.88 Mn |
| Mar 31, 2023 | 9.74 Mn |
| Dec 31, 2022 | 8.46 Mn |
| Sep 30, 2022 | 19.54 Mn |
| Jun 30, 2022 | 8.93 Mn |
| Mar 31, 2022 | 4.86 Mn |
| Dec 31, 2021 | 3.22 Mn |
| Sep 30, 2021 | 3.79 Mn |
| Jun 30, 2021 | 4.72 Mn |